Episodios

  • Directors' Talk DPHARM 2025 - AI Sessions; Part III

    Directors' Talk DPHARM 2025 - AI Sessions; Part III
    Jul 25 2025
    In this podcast series, DPHARM Director Tracey Kimball with Valerie Bowling, Executive Director of the Conference Forum, break down what to expect at DPHARM 2025. Part III of this podcast series covers sessions addressing AI in Clinical Trials.
    Más Menos
    6 m
  • Innovations in Manufacturing to Make CAR-T More Accessible and Affordable

    Innovations in Manufacturing to Make CAR-T More Accessible and Affordable
    Jul 25 2025
    Summary:
    Accessibility to CAR-T is limited by traditional manufacturing, with its associated challenges and high cost. Moffitt Cancer Center's Chief BioEngineering Officer, Dr Greg Sawyer, highlights Moffitt's significant progress in enhancing T cell potency and boosting efficacy through engineering strategies. Dr Sawyer discusses assays enabling precise asessment of T cell potency, developments in manufacturing, and more, and the resulting impact on scalability and efficiency.

    This presentation comes from the March 2025 Immuno-Oncology 360º Summit. For more information, go to IO360summit.com.
    Más Menos
    20 m
  • Achieving Oral Delivery of Peptides through Formulation and Molecule Design Approaches

    Achieving Oral Delivery of Peptides through Formulation and Molecule Design Approaches
    Jul 25 2025
    Summary:
    In this podcast, Pharma and Drug Delivery executives from Novartis, AstraZeneca, Merck and Quotient Sciences discuss traditional and novel approaches to improve the oral delivery of peptides including:
    • The biopharmaceutics of oral peptide and the use of permeation enhancers
    • Alternate sites for the delivery of oral peptides throughout the GI tract
    • Improving oral exposure through ingestible devices
    • Delivering ASOs and other large synthetics
    • Next-generation approaches for delivery

    This presentation was recorded at the October 2024 PODD: Partnership Opportunities in Drug Delivery conference. For more information, go to Drug-Delivery.org.
    Más Menos
    29 m
  • Catalyzing Change: The Business Imperative of Patient-Centric Drug Development

    Catalyzing Change: The Business Imperative of Patient-Centric Drug Development
    Jul 21 2025
    Summary:
    In this podcast, Dr Anthony Yanni, SVP, Head of Patient Centricity at Astellas, presented the business rationale for patient-centric medicine development, how it's disrupting the pharmaceutical industry and why companies have to act swiftly to remain competitive.

    Dr Yanni discusses how to align medicine development with healthcare delivery and the necessary cultural transformation that is critical to sustaining it, practical steps to incorporate patient input early into the R&D process, operationalizing patient-centric processes, methods to measure impact, and more.

    This presentation was recorded at the March 2025 Patients as Partners in Clinical Research conference. For more information, go to PatientsAsPartnersConference.com.
    Más Menos
    26 m
  • How Emerging Biopharma CMOs Can Better Partner with Patient Organizations

    How Emerging Biopharma CMOs Can Better Partner with Patient Organizations
    Jul 21 2025
    This podcast features a panel discussion from the 2025 Chief Medical Officer Summit 360° with biotech CMOs across indications about how CMOs can better develop drugs patients want and derisk development by partnering with patient organizations. Specifically, the panelists address:
    • Patient voice driving drug development forward
    • Supporting health equity and patient access after approval
    • Building genuine relationships and engaging early to get to the right patients at the right time and for better advocacy about your research
    • Building a community of awareness and working with patients for support throughout the regulatory process
    • Integrating the patient perspective in early
    • Real world examples and their impacts
    To learn more about the Chief Medical Officer Summit 360°, please visit CMO360.org.
    Más Menos
    32 m
  • Joint Site and Sponsor Perspectives on Innovative Solutions Addressing Sites Challenges

    Joint Site and Sponsor Perspectives on Innovative Solutions Addressing Sites Challenges
    Jul 21 2025
    Summary:
    In this session, pharma sponsors and sites gather to present innovative solutions to solve site challenges in workforce and capability gaps, increasing technology burden, patient enrollment and managing clinical trial protocol complexity. They discuss efforts to address those challenges, early impacts and outcomes.

    In this panel:
    • Dennis Salotti, MS, MBA, Executive Director & Head of Clinical Outsourcing & Innovation, Jazz Pharmaceuticals
    • Kristin Herman, Executive Director, Clinical Trials Office, Sidney Kimmel Cancer Center, Jefferson Health
    • Eileen Hughes, RN, BS, Senior Manager, Site Partnerships, CSL Behring
    • Lisa Kiehne, SVP, Operations, The START Center for Cancer Research
    • Christopher McNair, PhD, Associate Director, Data Science and Cancer Informatics, Sidney Kimmel Cancer Center, Jefferson Health
    • Tracey Robertson, Head of Patient and Site Engagement Capability Management, Boehringer Ingelheim

    This panel was recorded at the 2024 DPHARM: Disruptive Innovations to Advance Clinical Research. For more information about the 2025 DPHARM, visit DPHARMconference.com.
    Más Menos
    49 m
  • What to Expect at the CRAACO: Clinical Research as a Care Option 2025 Event

    What to Expect at the CRAACO: Clinical Research as a Care Option 2025 Event
    Jul 8 2025
    Conference Forum Director Valerie Bowling and CRAACO Producer Danny McCarthy break down what to expect at the 2025 CRAACO program. This podcast covers the keynotes, panels and key themes for this year's event, including:
    • How to develop a clinical research program within a community cancer center, with Dr Brian Slomovitz, Mount Sinai Medical Center Miami Beach
    • Turning clinical environments into learning health systems, with Dr Laura Esserman, UCSF Carol Franc Buck Breast Cancer Center
    • How to better partner with multiple location health system structures for clinical trials
    • Addressing medical staff shortages and challenges to support clinical research
    • The impact of clinical trial participation on cost and performance in cancer centers
    • EHR and AI advancements for clinical research
    • And more

    Want to know more about CRAACO? Visit CRAACOevent.com.
    Más Menos
    11 m
  • Directors' Talk PODD 2025 - Keynotes & Key Themes

    Directors' Talk PODD 2025 - Keynotes & Key Themes
    Jun 30 2025
    PODD: Partnership Opportunities in Drug Delivery Directors Valerie Bowling and Andrew Goldstein break down what to expect at PODD 2025. This podcast covers keynotes and key themes for this year's event, including:
    • Regeneron Co-Founder and CSO, Dr George Yancopoulos
    • Novo Nordisk Chief Scientific Advisor, Dr Lotte Bjerre Knudsen
    • MIT's Robert Langer
    • Patient Keynote, Jimi Olaghere
    • Northeastern University's Dr Mansoor Amiji
    • Drug Delivery Technology Presentation Tracks
    • Networking Opportunities
    • and more
    Want to know more about PODD? Check it out at PODDConference.com.
    Más Menos
    11 m